Risultati della ricerca - Ming‐Hong Hao
- Mostra 1 - 5 risultati su 5
-
1
Designing potential energy functions for protein folding di Ming‐Hong Hao, Harold A Scheragat
Pubblicazione 1999Revisão -
2
Covalent ERα Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant Breast Cancer di Craig Furman, Xiaoling Puyang, Zhaojie Zhang, Zhenhua J. Wu, Deepti Banka, Kiran Aithal, Lee A. Albacker, Ming‐Hong Hao, Sean Irwin, Amy Kim, Meagan Montesion, Alyssa Moriarty, Karthikeyan Murugesan, Tuong-Vi Nguyen, Victoria Rimkunas, Tarek Sahmoud, Michael J. Wick, Shihua Yao, Xun Zhang, Hao Zeng, Frédéric H. Vaillancourt, David M. Bolduc, Nicholas Larsen, Guo Zhu Zheng, Sudeep Prajapati, Ping Zhu, Manav Korpal
Pubblicazione 2022Artigo -
3
H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma di Jaya Julie Joshi, Heather Coffey, Erik Corcoran, Jennifer J. Tsai, Chia‐Ling Huang, Kana Ichikawa, Sudeep Prajapati, Ming‐Hong Hao, Suzanna Bailey, Jeremy Wu, Victoria Rimkunas, Craig Karr, Vanitha Subramanian, Pavan Kumar, Crystal MacKenzie, Raelene Hurley, Takashi Satoh, Kun Yu, Eunice Park, Nathalie Rioux, Amy Kim, Weidong G. Lai, Lihua Yu, Ping Zhu, Silvia Buonamici, Nicholas Larsen, Peter Fekkes, John Wang, Markus Warmuth, Dominic J. Reynolds, Peter G. Smith, Anand Selvaraj
Pubblicazione 2017Artigo -
4
Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer di Manav Korpal, Xiaoling Puyang, Zhenhua J. Wu, Roland Seiler, Craig Furman, Htoo Zarni Oo, Michael Seiler, Sean Irwin, Vanitha Subramanian, Jaya Julie Joshi, Chris Kedong Wang, Victoria Rimkunas, Davide Tortora, Hua Yang, Namita Kumar, Galina Kuznetsov, Mark Matijevic, Jesse C. Chow, Pavan Kumar, Jian Zou, Jacob Feala, Laura Corson, Ryan E. Henry, Anand Selvaraj, Allison Davis, Kristjan Bloudoff, James J. Douglas, Bernhard Kiss, Morgan E. Roberts, Ladan Fazli, Peter C. Black, Peter Fekkes, Peter G. Smith, Markus Warmuth, Lihua Yu, Ming‐Hong Hao, Nicholas Larsen, Mads Daugaard, Ping Zhu
Pubblicazione 2017Artigo -
5
Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer di Xiaoling Puyang, Craig Furman, Guo Zhu Zheng, Zhenhua J. Wu, Deepti Banka, Kiran Aithal, Sergei Agoulnik, David M. Bolduc, Silvia Buonamici, Benjamin Caleb, Subhasree Das, Sean Eckley, Peter Fekkes, Ming‐Hong Hao, Andrew Hart, René Houtman, Sean Irwin, Jaya Julie Joshi, Craig Karr, Amy Kim, Namita Kumar, Pavan Kumar, Galina Kuznetsov, Weidong G. Lai, Nicholas Larsen, Crystal MacKenzie, Lesley‐Ann Martin, Diana Melchers, Alyssa Moriarty, Tuong-Vi Nguyen, John D. Norris, Morgan O’Shea, Sunil Pancholi, Sudeep Prajapati, Sujatha Rajagopalan, Dominic J. Reynolds, Victoria Rimkunas, Nathalie Rioux, Ricardo Ribas, Amy Siu, Sasirekha Sivakumar, Vanitha Subramanian, Michaël Thomas, Frédéric H. Vaillancourt, John Wang, Suzanne E. Wardell, Michael J. Wick, Shihua Yao, Lihua Yu, Markus Warmuth, Peter G. Smith, Ping Zhu, Manav Korpal
Pubblicazione 2018Artigo
Strumenti per la ricerca:
Soggetti correlati
Biology
Cancer research
Receptor
Internal medicine
Medicine
Antagonist
Breast cancer
Cancer
Chemistry
Estrogen receptor
Fulvestrant
Genetics
Pharmacology
Biochemistry
Biological system
Cell biology
Cell culture
Computational biology
Computer science
Context (archaeology)
Engineering
Epistemology
Estrogen receptor alpha
FGF19
Fibroblast growth factor
Fibroblast growth factor receptor
Fibroblast growth factor receptor 4
Folding (DSP implementation)
Gene
Gene knockdown